Response to: Lavey, RS et al. Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IB-IVA carcinoma of the cervix: a Southwest Oncology Group Study. Gynecol. Oncol. 95 (2004) 145-151
about
Response to: Lavey, RS et al. Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IB-IVA carcinoma of the cervix: a Southwest Oncology Group Study. Gynecol. Oncol. 95 (2004) 145-151
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Response to: Lavey, RS et al. ...... ecol. Oncol. 95 (2004) 145-151
@en
Response to: Lavey, RS et al. ...... ecol. Oncol. 95 (2004) 145-151
@nl
type
label
Response to: Lavey, RS et al. ...... ecol. Oncol. 95 (2004) 145-151
@en
Response to: Lavey, RS et al. ...... ecol. Oncol. 95 (2004) 145-151
@nl
prefLabel
Response to: Lavey, RS et al. ...... ecol. Oncol. 95 (2004) 145-151
@en
Response to: Lavey, RS et al. ...... ecol. Oncol. 95 (2004) 145-151
@nl
P1433
P1476
Response to: Lavey, RS et al. ...... ecol. Oncol. 95 (2004) 145-151
@en
P2093
Thomas Hess
P356
10.1016/J.YGYNO.2005.01.033
P577
2005-06-01T00:00:00Z